RFPopen🌐 Canada (CanadaBuys)cb-93-39360034
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Department of Health (HC)
Description
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids. Amendment 1 - Questions & Answers #1 and Amendment to Annex B - SOW Stream 2 Amendment 2 - Questions & Answers #2 and Amendment to Annex A - SOW Stream 1 Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of three categories of emerging drugs: novel synthetic opioids, synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the Office of Legislative and Regulatory Affairs (OLRA) to make more informed regulatory science decisions. For all three streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Novel Opioids, Stimulants, and Synthetic Cannabinoids in three (3) separate streams to Health Canada. Stream 1 - In vitro pharmacological testing of emerging opioids at the Mu Opioid Receptor (MOR). Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream, two (2) streams or all three (3) streams. Up to three (3) contracts may be awarded under this request for proposal.
Documents (10)?
- Download📎 annexe-c---edt-flux-3-final.pdfapplication/pdf · 236 KB
- Download📎 appendix-a---sow-stream-1-amended-20260901.pdf—Upstream 403 Forbidden
- Download📎 appendix-a---sow-stream-1-final.pdfapplication/pdf · 376 KB
- Download📎 appendix-b---sow-stream-2-amendment-1.pdfapplication/pdf · 367 KB
- Download📎 appendix-b---sow-stream-2-final.pdfapplication/pdf · 306 KB
- Download📎 appendix-c---sow-stream-3-final.pdf—Upstream 403 Forbidden
- Download📎 english-rfp-1000273405-final.pdfapplication/pdf · 840 KB
- Download📎 qs-as-1.pdfapplication/pdf · 124 KB
- Download📎 qs-as-2.pdfapplication/pdf · 74 KB
- Download📎 questions-and-answers-3.pdfapplication/pdf · 53 KB
Details?
- Posted
- Aug 20, 2026
- Response deadline
- Sep 25, 2026, 12:00 PM UTC (9d)
- Type
- RFP
- Procurement method
- Competitive - Open bidding
- Status
- Open
- Commodity code
- *51000000
- Trade agreements
- *Canada-Colombia Free Trade Agreement *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Canada-Panama Free Trade Agreement *Canada-Peru Free Trade Agreement (CPFTA) *Comprehens
- Buyer
- Department of Health (HC)
- Jurisdiction
- Canada (CanadaBuys)
- Location
- *National Capital Region (NCR)
- Reference #
- cb-93-39360034
- Solicitation #
- 1000273405
- Has Description
- true
- Amendments
- 4
- Last amended
- Sep 15, 2026
- Country
- Canada
- Contact Info Postalcode
- K1A0K9
- Unspsc Description
- *Drugs and Pharmaceutical Products
- Notice Type
- Request for Proposal
- Amendment Number
- 004
- Contact Info City
- Ottawa
- Selection Criteria
- Highest Combined Rating of Technical Merit and Price
- Regions Of Opportunity
- *Canada
- Tender Description
- Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids. Amendment 1 - Questions & Answers #1 and Amendment to Annex B - SOW Stream 2 Amendm
- Contact Info Province
- National Capital Region (NCR)
- Contact Info Address Line
- 200 Eglantine Driveway
- Contracting Entity Address Postal Code
- K1A 0K9
- Contracting Entity Address Province
- Ontario
Contact
Similar open opportunities
See opportunities like this one
GovBidAlerts matches this solicitation to similar open bids across 120,000+ open bids from 2,400+ sources. Create a free account to unlock them.
Create free accountno credit card required
This listing is a summary from Canada (CanadaBuys)'s open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.